首页 › 多发性骨髓瘤 › 得克萨斯州 › San Antonio
San Antonio TX 多发性骨髓瘤临床试验
7项针对 多发性骨髓瘤的研究正在 San Antonio及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
招募中3 期
- Texas Transplant Institute, San Antonio
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
招募中2 期
- START San Antonio, San Antonio
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
招募中3 期
- Research Site, San Antonio
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中2 期
- Methodist HealthCare System of San Antonio Clinical Trials Office, Texas Transplant Institute, San Antonio
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
招募中3 期
- University of Texas Health Science Center at San Antonio, San Antonio
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
招募中2 期
- Texas Oncology - San Antonio, San Antonio
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
招募中3 期
- GSK Investigational Site, San Antonio
其他城市的 多发性骨髓瘤试验
- New York City, NY59 项研究
- Boston, MA45 项研究
- Atlanta, GA42 项研究
- Houston, TX39 项研究
- Durham, NC36 项研究
- Nashville, TN31 项研究
- Denver, CO26 项研究
- St. Louis, MO26 项研究
- Rochester, MN25 项研究
- Columbus, OH25 项研究
- Chicago, IL24 项研究
- Milwaukee, WI23 项研究
San Antonio的其他研究
- 非小细胞肺癌60 项研究
- 乳腺癌45 项研究
- 转移性癌症44 项研究
- 结直肠癌43 项研究
- 癌症（所有类型）41 项研究
- 肥胖症39 项研究
- 2型糖尿病37 项研究
- 超重34 项研究
- 卵巢癌33 项研究
- 胰腺癌33 项研究
- 肺癌27 项研究
- 前列腺癌27 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。